Evidence map›Paper›PMID 41229530›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2025

Incidence and Short-Term Prognosis of Acute-On-Chronic Liver Failure Defined by Japanese Criteria: A Single-Center Retrospective Cohort Study From Urban Japan.

Hidehiro Kamezaki, Terunao Iwanaga, Takahiro Maeda, Junichi Senoo, Sadahisa Ogasawara, Shingo Nakamoto, Naoya Kato

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hidehiro KamezakiDepartment of Gastroenterology Eastern Chiba Medical Center Togane Japan.ORCID https://orcid.org/0000-0003-2238-9558
Terunao IwanagaDepartment of Gastroenterology Eastern Chiba Medical Center Togane Japan.
Takahiro MaedaDepartment of Gastroenterology Eastern Chiba Medical Center Togane Japan.
Junichi SenooDepartment of Gastroenterology Eastern Chiba Medical Center Togane Japan.
Sadahisa OgasawaraDepartment of Gastroenterology, Graduate School of Medicine Chiba University Chiba Japan.ORCID https://orcid.org/0000-0002-6540-9064
Shingo NakamotoDepartment of Gastroenterology, Graduate School of Medicine Chiba University Chiba Japan.
Naoya KatoDepartment of Gastroenterology, Graduate School of Medicine Chiba University Chiba Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Acute-on-chronic liver failure (ACLF) carries high short-term mortality, but real-world evidence under the Japanese ACLF criteria remains limited. We assessed incidence, clinical profile, outcomes, and prognostic factors at a tertiary center in urban Japan. Methods: We retrospectively reviewed 363 consecutive hospitalizations of patients with cirrhosis (2014-2022) at a tertiary care center in Japan. ACLF per Japanese criteria was categorized as confirmed (meeting both PT INR/PT activity and bilirubin thresholds) or extended (meeting either biochemical criterion alone). We pre-specified a parsimonious Cox model with age (per 10 years) and MELD-Na (per 5 points); the primary outcome was time to all-cause death within 90 days (administrative censoring at day 90). Results: ACLF occurred in 40/363 (11.0%) patients (confirmed Conclusions: In this Japanese single center cohort, ACLF (per national criteria) was not rare and carried substantial short-term mortality. Age and MELD-Na were dominant prognostic factors, underscoring early trigger control (notably infection, gastrointestinal bleeding, and alcohol cessation) and timely risk stratification in routine care.

Indexed as

acute‐on‐chronic liver failureinfectionsliver cirrhosis

Identifiers

PMID41229530
PMCPMC12602991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.